A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections

An Open Label, Non-comparative, Multicenter Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infection

The purpose of this study is to evaluate the efficacy and safety of Vfend for the treatment of fungal infections

Inclusion Criteria:

• Systemic or invasive fungal infection
• Infection caused by organism for which there is no current treatment or infection with evidence of failure and/or intolerance to treatment with approved antifungal agents

Exclusion Criteria:

• Liver function test abnormalities
• Renal disease
• Fungal infections not considered to be invasive or systemic